Andy Scharenberg, Umoja Biopharma CEO
January 4, 2024 11:16 AM EST
Deals
Cell/Gene Tx

Ab­b­Vie taps Umo­ja for new in vi­vo CAR-T deal

Lei Lei Wu

News Reporter

Ab­b­Vie penned two deals with Umo­ja Bio­phar­ma for its in vi­vo CAR-T cell ther­a­py pro­grams, the com­pa­nies an­nounced Thurs­day.

Ab­b­Vie gets …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

Eu­ro­pean drug reg­u­la­tor re­vers­es opin­ion on Ei­sai and Bio­gen's Alzheimer's drug

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

No­vo Nordisk to phase out its pro­duc­tion of hu­man in­sulin pens glob­al­ly

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times